|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03689 KANGHUA HEALTH
Nominal 
1.900 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 937,633 | -4.473% | 2,024,200 | 2,055,670 | 2,041,858 | 1,845,633 |
| Cost of Sales | (779,524) | -5.283% | (1,655,277) | (1,733,797) | (1,677,488) | (1,584,283) |
| Gross Profit | 158,109 | -0.267% | 368,923 | 321,873 | 364,370 | 261,350 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (13,718) | 4472.667% | (4,500) | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,702) | -73.533% | (44,536) | (4,277) | (2,768) | (4,210) | |
| Profit / (Loss) on Disposal | 8,520 | -55.643% | 18,940 | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (23,158) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 48,415 | -8.623% | 142,300 | 63,055 | 153,429 | 69,309 | |
| Taxation | (12,427) | -39.122% | (47,787) | (52,582) | (62,406) | (43,025) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,305 | -74.589% | 5,078 | 4,864 | 30,039 | 33,413 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 38,293 | -8.042% | 99,591 | 15,337 | 121,062 | 59,697 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,430 | 61.888% | 11,791 | 17,627 | 7,137 | 11,817 |
| Depreciation & Amortisation | 98,437 | 41.565% | 139,459 | 149,855 | 143,079 | 149,441 |
| Directors' Emoluments | -- | -- | -- | 3,625 | 2,493 | 3,103 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 11.500 | -8.000% | 29.800 | 4.600 | 36.200 | 17.900 |
| DPS (cts) | 0.000 | -- | 16.000 | 15.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 53.691% | 326.087% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.845 | 0.838 | 0.611 | 0.662 |
| NBV per share ($) | 4.467 | -- | 4.513 | 4.305 | 4.259 | 4.483 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 38,293 |
| %Change | -8.042% |
| EPS / (LPS) | RMB 0.115 |
| NBV Per Share (¥) | RMB 4.467 |